In addition, a study by Yamada et al. [63] revealed that PC cells expressed significantly higher levels of ADAM9 in comparison to normal pancreatic epithelial cells, which may suggest that this protein plays a role in the progression of PC and may present promising target for the diagnosis of this malignancy and treatment of patients [63]. This evidence concerns the gene ADAM9 and pachyonychia congenita.